(5Z)-5-(4-Hydroxy-3-methoxy)benzylidene-2-{[4-(4-methyl-piperazin-1-yl)-phenyl]amino}-3,5-dihydro-4H-imidazol-4-one

ID: ALA5200518

Chembl Id: CHEMBL5200518

PubChem CID: 168291324

Max Phase: Preclinical

Molecular Formula: C22H25N5O3

Molecular Weight: 407.47

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C2\N=C(Nc3ccc(N4CCN(C)CC4)cc3)NC2=O)ccc1O

Standard InChI:  InChI=1S/C22H25N5O3/c1-26-9-11-27(12-10-26)17-6-4-16(5-7-17)23-22-24-18(21(29)25-22)13-15-3-8-19(28)20(14-15)30-2/h3-8,13-14,28H,9-12H2,1-2H3,(H2,23,24,25,29)/b18-13-

Standard InChI Key:  HRVRSEHLJQHGFO-AQTBWJFISA-N

Alternative Forms

1. Parent:

   

   ALA5200518

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 407.47

Molecular Weight (Monoisotopic): 407.1957

AlogP: 2.09

#Rotatable Bonds: 4

Polar Surface Area: 89.43

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.49

CX Basic pKa: 7.95

CX LogP: 2.26

CX LogD: 1.75

Aromatic Rings: 2

Heavy Atoms: 30

QED Weighted: 0.67

Np Likeness Score: -0.66

References

1. Tahtouh T, Durieu E, Villiers B, Bruyère C, Nguyen TL, Fant X, Ahn KH, Khurana L, Deau E, Lindberg MF, Sévère E, Miege F, Roche D, Limanton E, L'Helgoual'ch JM, Burgy G, Guiheneuf S, Herault Y, Kendall DA, Carreaux F, Bazureau JP, Meijer L..  (2022)  Structure-Activity Relationship in the Leucettine Family of Kinase Inhibitors.,  65  (2.0): [PMID:34928152] [10.1021/acs.jmedchem.1c01141]

Source

Source(1):

• Scientific Literature